Substantial evidence exists that ApoE contributes to AD pathogenesis by modulating Aβ aggregation and clearance, and by regulating brain lipid metabolism and synaptic functioning through ApoE receptors such as those of the low‐density lipoprotein (LDL) receptor family 9, 10, 11, 12. Here, APOE is linked to Alzheimer disease.